Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2013
11/14/2013WO2013167582A1 Methods and pharmaceutical compositions for prevention or treatment of chronic obstructive pulmonary disease
11/14/2013WO2013167554A1 Pharmaceutical combinations for the treatment of metabolic disorders
11/14/2013WO2013167514A1 New 2,3-dihydro-furo[2,3-c]pyridines, their use as modulators of the g-protein-coupled receptor gpr119 and pharmaceutical compositions comprising them
11/14/2013WO2013167475A1 Anabolic compounds for treating and preventing bone loss diseases
11/14/2013WO2013167453A1 Process for manufacturing a pharmaceutical dosage form comprising nifedipine and candesartan cilexetil
11/14/2013WO2013167403A1 Substituted 6-(4-hydroxy-phenyl)-1h-pyrazolo[3,4-b]pyridine derivatives as kinase inhibitors
11/14/2013WO2013167303A1 Sugar compositions for treating hemophilia a and/or von willebrand disease
11/14/2013WO2013167295A1 (r) -nifuratel, its use for the treatment of infections and synthesis of (r) and (s) -nifuratel
11/14/2013WO2013167233A1 Tobramycin formulation
11/14/2013WO2013167220A1 Use of cyclohexanol ethers having antimicrobial properties
11/14/2013WO2013167177A1 Gpr17 receptor modulators.
11/14/2013WO2013167117A1 Polysubstituted arenes and synthesis thereof
11/14/2013WO2013167112A1 Composition for nasal application
11/14/2013WO2013166989A1 Thiazole compound and use thereof
11/14/2013WO2013166966A1 Polymorphs of flourine-containing deuterium-substituted omega-diphenylurea or salts thereof
11/14/2013WO2013166952A1 Substituted aminoquinazolines useful as kinases inhibitors
11/14/2013WO2013166901A1 Application of (e)-nitrogen-(4-cinnamic amide butyl) benzamide in preparation of antineoplastic medicament
11/14/2013WO2013166862A1 Diaryl[a, g]quinolizidine compound, preparation method therefor, pharmaceutical composition, and uses thereof
11/14/2013WO2013166654A1 Permeable glycosidase inhibitors and uses thereof
11/14/2013WO2013166621A1 1-(dihydronaphthalenyl)pyridones as melanin-concentrating hormone receptor 1 antagonists
11/14/2013WO2013166618A1 PRODRUGS OF 4,9-DIHYDROXY-NAPHTHO[2,3-b]FURANS FOR CIRCUMVENTING CANCER MULTIDRUG RESISTANCE
11/14/2013WO2013166576A1 Method for producing a plant extract and fraction, pharmaceutical compositions and use thereof
11/14/2013WO2013166563A1 Method for producing a plant extract from desmodium and extract thereof
11/14/2013WO2013149148A8 Dosage forms of halofuginone and methods of use
11/14/2013WO2013142253A3 TREATMENT OF PANCREATIC AND RELATED CANCERS WITH 5-ACYL-6,7-DIHYDROTHIENO[3,2-c]PYRIDINES
11/14/2013WO2013129977A3 Pharmaceutical composition for injections having neuroprotector, antiamnaesic, antioxidant, antihypoxic and antiischaemic activity (embodiments)
11/14/2013WO2013129970A3 Pharmaceutical composition having vasoconstricting, anticongestant and anti-inflammatory activity (embodiments)
11/14/2013WO2013107839A3 Phospholipid compounds for use in skin cancer treatment
11/14/2013WO2013103919A3 Compositions and methods for treating metabolic disorders
11/14/2013WO2013102842A4 Device and composition for drug release
11/14/2013WO2013085422A3 Antitubercular composition and method for producing same
11/14/2013WO2013079586A4 Carboxamide-substituted heteroaryl-pyrazoles and the use thereof
11/14/2013WO2013059559A3 Compounds and methods for enhancing innate immune responses
11/14/2013WO2013052433A8 Methods and compositions for reducing food intake and body weight gain in animals
11/14/2013WO2012154679A8 Tricyclic pyrazole sulfonamide compounds and methods of making and using same
11/14/2013WO2012149608A8 Prenylated hydroxystilbenes
11/14/2013WO2012136385A8 6,7-dihydro-[1,3,4]thiadiazolo-[3,2-a][1,3]diazepin derivative and pharmaceutical composition containing the same as neuromuscular blocker or skeletal muscle relaxant, and method for the preparation
11/14/2013WO2012116280A3 Formulations useful for spray drying vaccines
11/14/2013WO2012082470A8 The use anti-cxcl16 and anti-cxcr6 antibodies for the treatment or detecting cancer
11/14/2013WO2012076977A9 Method of extracting active molecules from natural resins and use thereof
11/14/2013WO2012064667A3 Treatment of addiction and impulse-control disorders using pde7 inhibitors
11/14/2013WO2012061683A3 Methods for treating cancer
11/14/2013WO2012061290A3 Pesticidal compositions and processes related thereto
11/14/2013US20130303985 Needle assisted jet injection administration of testosterone compositions
11/14/2013US20130303976 Methods and Systems for Conditioning in Surgery
11/14/2013US20130303790 Pseudopolymorphic Forms Of A HIV Protease Inhibitor
11/14/2013US20130303705 Crosslinked polymers containing biomass derived materials
11/14/2013US20130303628 Curcuminoid solid dispersion formulation
11/14/2013US20130303625 Agent for the prevention, improvement or treatment of retinal disease
11/14/2013US20130303624 Ophthalmic composition comprising geranylgeranylacetone
11/14/2013US20130303623 Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
11/14/2013US20130303621 Method For Inhibiting Osteoclast Development
11/14/2013US20130303620 Injectable Capsaicin
11/14/2013US20130303619 Antibacterial Compositions
11/14/2013US20130303618 Solid Pharmaceutical Compositions Containing Pregabalin
11/14/2013US20130303617 Compositions containing as the active ingredient components from salvia sclarea seed
11/14/2013US20130303616 Therapeutic use of compounds
11/14/2013US20130303615 Antimicrobial compositions and methods
11/14/2013US20130303614 Agent for inhibiting elevation in blood glucose level
11/14/2013US20130303613 NRF2 Screening Assays and Related Methods and Compositions
11/14/2013US20130303612 Solid dosage form comprising a fibrate
11/14/2013US20130303611 Use of phenethyl caffeate derivatives in the preparation of a medicament against tumor angiogenesis
11/14/2013US20130303607 Triterpenoids and Compositions Containing the Same
11/14/2013US20130303606 Platinum compounds as treatment for cancers, and related methods, kits, and compositions
11/14/2013US20130303604 Method of Using Tea Polyphenols for Prevention and Treatment of Malignant Tumors in a Hematopoietic System
11/14/2013US20130303603 Method of preparing a muscadine pomace extract
11/14/2013US20130303600 Anti-angiogenic composition containing macrolactin a and a derivative thereof as active ingredients
11/14/2013US20130303592 Treatment of Cancer by Inhibition of IGFBPs and Clusterin
11/14/2013US20130303586 Oligonucleotide compositions with enhanced efficiency
11/14/2013US20130303585 Small molecule rnase inhibitors and methods of use
11/14/2013US20130303584 Methods and compositions for treating cornelia de lange syndrome
11/14/2013US20130303583 Methods of treating headaches using 5-ht agonists in combination with long-acting nsaids
11/14/2013US20130303578 Phenylamino-benzoxazole substituted carboxylic acids, method for their production and use thereof as medicaments
11/14/2013US20130303575 Administration of an inhibitor of hdac
11/14/2013US20130303573 Brown Adipocyte Progenitors in Human Skeletal Muscle
11/14/2013US20130303570 Modulators of Cystic Fibrosis Transmembrane Conductance Regulator
11/14/2013US20130303569 Use of high dose laquinimod for treating multiple sclerosis
11/14/2013US20130303568 Substituted 2-Aminoacetamides and the Use Thereof
11/14/2013US20130303566 Method for treating macular degeneration
11/14/2013US20130303564 Method for treating a neurodegenerative disorder
11/14/2013US20130303563 Treatment of peritoneal injury using jak inhibitors
11/14/2013US20130303562 Chemical and rnai suppressors of neurotoxicity in huntington's disease
11/14/2013US20130303561 Systems and Methods for Treating an Opioid-Induced Adverse Pharmacodynamic Response
11/14/2013US20130303560 Combination
11/14/2013US20130303559 Benzimidazole and pyrazolopyridine derivatives for treating and/or preventing cardiovascular diseases
11/14/2013US20130303557 Pharmaceutical compositions and methods of treating dry eye disorders
11/14/2013US20130303556 Mucosal bioadhesive slow release carrier for delivering active principles
11/14/2013US20130303554 Use of a dpp-4 inhibitor in sirs and/or sepsis
11/14/2013US20130303552 Novel inhibitors of secretion of hepatitis b virus antigens
11/14/2013US20130303551 Pyrimidinone derivatives as fatty acid synthase inhibitors
11/14/2013US20130303548 Indication for use of niacin (nicotinic acid) for treatment, prevention and reversal of fatty liver disease
11/14/2013US20130303546 Non-sedating antihistamine injection formulations and methods of use thereof
11/14/2013US20130303543 Protection of renal tissues from ischemia through inhibition of the proliferative kinases cdk4 and cdk6
11/14/2013US20130303542 Substituted pyrazinamide compounds for inflammation and immune-related uses
11/14/2013US20130303540 5-methyl-1-(naphthalen-2-yl)-1h-pyrazole derivatives and their use in potentiating the effect of opioid analgesics
11/14/2013US20130303539 Compounds with trpv4 activity, compositions and associated methods thereof
11/14/2013US20130303538 4-Tolyl-ethynyl-octahydro-indole-1-ester derivatives
11/14/2013US20130303536 Combination of 10-Propargyl-10-Deazaaminopterin and Erlotinib for the Treatment of Non-Small Cell Lung Cancer
11/14/2013US20130303533 Azolopyridine and azolopyrimidine compounds and methods of use thereof
11/14/2013US20130303531 Tetra-substituted ndga derivatives via ether bonds and carbamate bonds and their synthesis and pharmaceutical use
1 ... 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 ... 7860